Dynavax Technologies | Marktkapitalisierung



Market Capitalization Veränderung Datum
AbbVie USD 347.08B 19.2B 2025-08
Adma Biologics USD 4.49B 147M 2025-08
Amgen USD 154.93B 4.8B 2025-08
AstraZeneca GBP 169.84B 45.67B 2025-08
Biogen USD 19.23B 818M 2025-08
BioMarin Pharmaceutical USD 10.92B 378M 2025-08
Bristol-Myers Squibb USD 90.13B 4.07B 2025-08
Dynavax Technologies USD 1.36B 167M 2025-08
Gilead Sciences USD 147.49B 9.58B 2025-08
Glaxosmithkline USD 76.16B 3.42B 2025-08
Merck USD 201.3B 2.52B 2025-08
Neurocrine Biosciences USD 12.83B 388M 2025-08
Novartis CHF 189.79B 66.39B 2025-08
Pfizer USD 139.98B 2.45B 2025-08
Regeneron Pharmaceuticals USD 62.39B 6.52B 2025-08
Sarepta Therapeutics USD 1.71B 30M 2025-08
TG Therapeutics USD 4.12B 1.59B 2025-08
Vertex Pharmaceuticals USD 97.9B 16.43B 2025-08


Dynavax Technologies Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.